Charles Theuer
Directeur Général chez TRACON PHARMACEUTICALS, INC.
Fortune : 717 132 $ au 30/06/2024
Profil
Charles P.
Theuer is currently the President, Chief Executive Officer & Director at TRACON Pharmaceuticals, Inc. He is also an Independent Director at 4D Molecular Therapeutics, Inc. and Oncternal Therapeutics, Inc. Previously, he worked as the Director-Clinical Oncology at Pfizer Inc. from 2003 to 2004 and as the Chief Medical Officer & VP-Clinical Development at TargeGen, Inc. from 2004 to 2006.
He also held the position of Assistant Professor-Surgical Oncology at the University of California, Irvine.
Additionally, he served as Principal at the National Cancer Institute from 1991 to 1993.
Dr. Theuer completed his undergraduate degree at the Massachusetts Institute of Technology in 1985.
He obtained his doctorate degrees from the University of California, Irvine in 2002 and the University of California, San Francisco in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2024 | 32 351 ( 0,06% ) | 679 047 $ | 30/06/2024 | |
| 12/03/2024 | 20 321 ( 0,76% ) | 32 514 $ | 30/06/2024 | |
| 20/06/2024 | 733 ( 0,02% ) | 5 571 $ | 30/06/2024 |
Postes actifs de Charles Theuer
| Sociétés | Poste | Début |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur Général | 02/08/2006 |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2016 |
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2018 |
Anciens postes connus de Charles Theuer
| Sociétés | Poste | Fin |
|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1993 |
| University of California, Irvine | Corporate Officer/Principal | - |
Formation de Charles Theuer
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
